학술논문

Lethal Dermal Sarcoma in Immunosuppressed Patients
Document Type
Academic Journal
Source
The Oncologist. September, 2022, Vol. 27 Issue 9, pe759, 3 p.
Subject
Massachusetts General Hospital
Transplantation of organs, tissues, etc. -- Research -- Health aspects
Sarcoma -- Research
Mortality -- Research
Metastasis -- Research
Immunotherapy -- Research -- Health aspects
Skin -- Health aspects -- Research
Organ transplant recipients -- Health aspects -- Research
Language
English
ISSN
1083-7159
Abstract
Skin cancer is the leading malignancy in immunosuppressed patients, including organ transplant recipients (OTRs), which is increasing in incidence as OTRs live longer. We performed a single-center case series of 4 patients with scalp pleomorphic dermal sarcoma and a history of multiple keratinocyte carcinomas. Outcomes included incidence of dermal sarcoma, dermal sarcoma-related mortality, and histopathologic findings. Out of more than 200 patients followed over a 3-year period in Massachusetts General Hospital High Risk Skin Cancer Clinics, all skin cancer-related deaths (2/2) were due to metastatic dermal sarcoma. Three of 4 patients diagnosed with scalp dermal sarcoma were OTRs and had been on at least one immunosuppressive medication for a median of 9 years. For patients who died from dermal sarcoma, the median time between diagnosis and death was 6 months. Our findings suggest pleomorphic dermal sarcoma contributes to skin cancer-related morbidity and mortality in OTRs. Key words: dermal sarcoma; immunosuppression; organ transplant recipient.
Introduction Skin cancer is a major cause of morbidity and mortality among immunosuppressed patients especially organ transplant recipients (OTRs) and is the leading cause of malignancy in this population. (1-6) [...]